299 related articles for article (PubMed ID: 28808918)
21. [Systemic thrombolysis after the administration of idarucizumab in acute ischemic stroke].
Pásztor M; Bereczki D; Szakács Z; May Z
Ideggyogy Sz; 2017 Jul; 70(7-8):284-288. PubMed ID: 29870643
[TBL] [Abstract][Full Text] [Related]
22. Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
Laxamana LC; Co COC; Yu JRT; Mojica CV; Iboleon-Dy MAM; Domingo AMC; Ilano KCS; Macrohon-Valdez MCZ
Clin Ther; 2020 Sep; 42(9):1840-1845. PubMed ID: 32778345
[TBL] [Abstract][Full Text] [Related]
23. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
Ohya Y; Makihara N; Wakisaka K; Morita T; Ago T; Kitazono T; Takaba H
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
[TBL] [Abstract][Full Text] [Related]
24. idarucizumab (PRAXBIND°). Don't rely too heavily on this dabigatran antidote.
Prescrire Int; 2016 Nov; 25(176):260-263. PubMed ID: 30715821
[TBL] [Abstract][Full Text] [Related]
25. Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
Alvarez Bravo G; Orts Castro E; Carvalho Monteiro G; López Zuazo I
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):e192-e193. PubMed ID: 28663010
[TBL] [Abstract][Full Text] [Related]
26. Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study.
J Neurosci Nurs; 2019 Feb; 51(1):E1. PubMed ID: 30614937
[No Abstract] [Full Text] [Related]
27. Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study.
Jala S; O'Brien E
J Neurosci Nurs; 2019 Feb; 51(1):21-25. PubMed ID: 30489421
[TBL] [Abstract][Full Text] [Related]
28. Reversal of dabigatran using idarucizumab: single center experience in four acute stroke patients.
Hieber M; Hollasch H; Heck D; Mächtel M; Geisen U; Niesen WD; Brich J; Harloff A
J Thromb Thrombolysis; 2018 Jul; 46(1):12-15. PubMed ID: 29633066
[TBL] [Abstract][Full Text] [Related]
29. Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan.
Tsai LK; Lin HJ; Chua SK; Liao PC; Yang YP; Chou PC; Lee CW; Lin MJ; Chen HM; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e27-e33. PubMed ID: 29122465
[TBL] [Abstract][Full Text] [Related]
30. Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects.
Reilly PA; van Ryn J; Grottke O; Glund S; Stangier J
Am J Med; 2016 Nov; 129(11S):S64-S72. PubMed ID: 27569674
[TBL] [Abstract][Full Text] [Related]
31. Management of Dabigatran-Associated Bleeding with Two Doses of Idarucizumab Plus Hemodialysis.
Marino KK; Santiago RA; Dew RB; Berliner N; Connors JM; Connell NT; Tucker JK
Pharmacotherapy; 2016 Oct; 36(10):e160-e165. PubMed ID: 27581709
[TBL] [Abstract][Full Text] [Related]
32. Acute stroke thrombolysis following dabigatran reversal using idarucizumab.
Harsha KJ; Thirunavukkarasu S; Butcher K
Neurol India; 2019; 67(2):568-570. PubMed ID: 31085880
[No Abstract] [Full Text] [Related]
33. Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation.
Tsai YT; Hsiao YJ; Tsai LK; Yen PS; Lin FY; Lu CH; Fang CW
J Neurol Sci; 2018 May; 388():155-157. PubMed ID: 29627012
[No Abstract] [Full Text] [Related]
34. Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis.
Romoli M; Matteo E; Migliaccio L; Gentile M; Mosconi MG; Scura GM; Naccarato M; Colangeli E; Candelaresi P; Andreone V; Giammello F; Fortunata Musolino R; Dell'Aera C; Sepe FN; Pronello E; Barbarini L; Caggiula M; Rizzo F; Petruzzellis M; Giorli E; Zedde ML; Anticoli S; Mangiardi M; Muto M; Diana F; De Angelis MV; Digiovanni A; Concari L; La Gioia S; Sessa M; Biguzzi S; Cordici F; Longoni M; Ruggiero M; Cenciarelli S; Eusebi P; Sacco S; Caso V; Paciaroni M; Ricci S; Zini A; Toni D; Giannandrea D
Eur Stroke J; 2023 Mar; 8(1):117-124. PubMed ID: 37021155
[TBL] [Abstract][Full Text] [Related]
35. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
Ritzenthaler T; Derex L; Davenas C; Bnouhanna W; Farghali A; Mechtouff L; Cho TH; Nighoghossian N
Rev Neurol (Paris); 2015 Sep; 171(8-9):613-5. PubMed ID: 25857461
[TBL] [Abstract][Full Text] [Related]
36. Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit.
Zhao H; Coote S; Pesavento L; Jones B; Rodrigues E; Ng JL; Ng F; Yan B; Parsons M; Campbell BC; Easton D; Donnan GA; Davis SM
Int J Stroke; 2019 Apr; 14(3):265-269. PubMed ID: 30014785
[TBL] [Abstract][Full Text] [Related]
37. Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants.
Okada T; Yoshimoto T; Wada S; Yoshimura S; Chiba T; Egashira S; Kimura S; Shiozawa M; Inoue M; Ihara M; Toyoda K; Takashima H; Koga M
J Am Heart Assoc; 2022 Oct; 11(19):e025809. PubMed ID: 36129032
[TBL] [Abstract][Full Text] [Related]
38. Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review.
Thibault N; Morrill AM; Willett KC
Am J Ther; 2018; 25(3):e333-e338. PubMed ID: 27175894
[TBL] [Abstract][Full Text] [Related]
39. Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
Rosenberg L; Gerstrøm G; Nybo M
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):407-410. PubMed ID: 27797449
[TBL] [Abstract][Full Text] [Related]
40. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
